MC

Milenko Cicmil

Partner at Cure Ventures

Boston, Massachusetts

Overview 

Milenko Cicmil is the Co-Founder and CEO of Tasca Therapeutics, a biotechnology company, and a Venture Partner at Cure Ventures. With a Ph.D. in biochemistry, he has held leadership roles at prominent organizations like Merck and Ipsen, focusing on drug discovery and development, and has a strong background in pharmacology and biotechnology. Cicmil's career highlights include serving as Vice President at FogPharma, leading translational biology efforts, and as Vice President at Merck overseeing in vivo pharmacology for immuno-oncology and immunomodulation, showcasing his expertise in drug development and innovative research initiatives.

Work Experience 

Uo

University of Reading

  • Visiting Research Fellow at Univ. of Reading, UK

    2020 - Current

CV

Cure Ventures

  • Partner

    2021

AMP Discovery

  • Chairman Of The Board AMP Discovery

    2021 - 2022

I

Ipsen

  • Vice President Global Head of external Innovation

    2019 - 2021

F

FogPharma

  • Vice President - Translational Biology

    2017 - 2019

FogPharma is a biopharmaceutical firm that develops precision medicines for the vast majority of therapeutic targets.

Raised $530,271,035.00 from venBio Partners, RA Capital Management, Google Ventures, Marshall Wace, Samsara BioCapital, SymBiosis, Nextech Invest, Catalio Capital Management, Fidelity and T. Rowe Price.

fogpharma.com
M

Merck

  • Director at Merck Innovation Hub

    2016 - 2017

  • Director Pharmacology Immuno-Oncology and Immunomodulation

    2013 - 2016

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

Raised $5,586,000.00 from Private Capital Advisors.

merck.com
M

Merck

  • Director In vivo Pharmacology R&I

    2011 - 2013

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

Raised $5,586,000.00 from Private Capital Advisors.

merck.com
A

AstraZeneca

  • Group Leader Integrative Pharmacology Discovery Bioscience - Inflammation

    2007 - 2011

  • Senior Research Scientist

    2004 - 2007

GH

GE Healthcare

  • Senior Research Scientist

    2002 - 2004

GE Healthcare provides a wide range of medical technologies and services to healthcare providers and researchers.

Raised $5,524,660,836.00 from Bill & Melinda Gates Foundation.

gehealthcare.com
CR

Cancer Research UK

  • Translational Science - Research Fellow

    2000 - 2002

Education 

Articles About Milenko

Relevant Websites